Max Robotics — Global Service Robot Directory + US Certification

About

Emir Hoti is a leading hepatobiliary and pancreatic surgeon whose research is driving the adoption and standardization of minimally invasive liver surgery (MILS) across Europe. His work focuses on comparing the safety, efficacy, and implementation of robotic, laparoscopic, and open approaches for treating liver malignancies, particularly hepatocellular carcinoma (HCC). Hoti’s landmark pan-European survey, published in 2021 and accumulating over 57 citations, provided a critical, real-world snapshot of how robotic and laparoscopic techniques are being adopted across the continent, identifying key barriers and trends in surgical practice. This foundational work was followed by a 2022 update, further solidifying his role as a key observer of the field’s evolution. In a pivotal 2023 study, Hoti used propensity score matching to rigorously benchmark perioperative outcomes of robotic, laparoscopic, and open liver resections for HCC, demonstrating the tangible benefits of the minimally invasive approach. Through this high-impact comparative research, Hoti is not only validating new technologies but also providing the evidence needed to guide surgical decision-making and improve patient recovery.